GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine.
Breast Cancer
OTHER: GlowCap device
Assess the usability of the GlowCap system by patients, \>60 years of age with early stage breast cancer., 2 years
Measure the acceptance and satisfaction of the GlowCap reminder system, with respect to medication adherence in patients \>60 years with early stage breast cancer taking adjuvant endocrine therapy., 2 years
The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine.